Department of Otolaryngology, Toho University School of Medicine, Tokyo, Japan.
Department of Otolaryngology, Toho University School of Medicine, Tokyo, Japan.
Auris Nasus Larynx. 2020 Apr;47(2):305-308. doi: 10.1016/j.anl.2019.05.008. Epub 2019 Jun 21.
Mikulicz's disease, an immunoglobulin G4-related disease (IgG4-RD) occurs frequently in the head and neck region but rarely in the larynx. We report a case of IgG4-RD with pseudotumor formation in the larynx. A 50-year-old man presented at our facility for a complete physical examination and diagnostic testing of a left arytenoid tumor. On examination, a large supraglottic mass was noted with signs of dyspnea. Movement disorder of the vocal fold was absent. The patient underwent surgery with general anesthesia to improve respiratory symptoms and a resected specimen was submitted for diagnosis. The pathology findings revealed lymph follicle formation, interstitial follicular fibrosis, angiogenesis, and inflammatory cell infiltration with plasmacytosis. Immunohistologic staining at high magnification revealed one hundred or more IgG4-positive plasma cells and fifty percent IgG4/IgG. In addition, obliterative phlebitis was observed. Medical history was positive for retroperitoneal fibrosis with serum IgG4 levels below the diagnostic criteria of IgG4-RD, but histological characteristics of IgG4-RD were met. The diagnosis of IgG4-RD was established, oral treatment with prednisolone (0.6 mg/kg/day) was initiated, and the tumor reduced in size. IgG4-RD may cause irreversible functional impairment. Early diagnosis and treatment are important in reducing the risk of permanent impairment of vocal fold mobility.
米库利茨病(Mikulicz's disease),一种免疫球蛋白 G4 相关疾病(IgG4-RD),常发生于头颈部,但喉部罕见。我们报告一例发生于喉部的 IgG4-RD 伴假瘤形成。一名 50 岁男性因左侧杓状软骨肿物,前来我院进行全面体检和诊断性检查。检查时,发现一个大的会厌上肿物,伴有呼吸困难的体征。声带运动障碍不明显。患者接受全身麻醉下的手术,以改善呼吸症状,并送检切除标本进行诊断。病理结果显示淋巴滤泡形成、间质滤泡纤维化、血管生成和炎症细胞浸润伴浆细胞增多。高倍镜下免疫组化染色显示一百个或更多 IgG4 阳性浆细胞和 50% IgG4/IgG。此外,还观察到闭塞性静脉炎。患者有腹膜后纤维化病史,血清 IgG4 水平低于 IgG4-RD 的诊断标准,但符合 IgG4-RD 的组织学特征。因此,诊断为 IgG4-RD,开始口服泼尼松龙(0.6mg/kg/天)治疗,肿瘤缩小。IgG4-RD 可能导致不可逆的功能障碍。早期诊断和治疗对于降低永久性声带运动障碍的风险很重要。